Detail page

Knowledge Web

Person

Dietrich Alexander Ruess (1983-)

Arzt

Name	Dietrich Alexander Ruess
Time	1983- (Date of birth and death)
Place	Filderstadt (Geburtsort) Deutschland
Academic degree	Dr. med.
Profession	Arzt (characteristic profession)
Variant	Dietrich A. Ruess Dietrich Ruess Dietrich Rueß
Related	Klinik für Allgemein- und Viszeralchirurgie (Freiburg im Breisgau)
Further information	Diss. Universität Tübingen, Medizinische Fakultät
Record type	Person
GND-Identifier	1024246965
Record ID	1024246965
Involved in show all A rare case of biliary adenocarcinoma mimicking an abdominal wall soft tissue tumor Vertical RAS pathway inhibition in pancreatic cancer drives therapeutically exploitable mitochondrial alterations 19Fluorine‐MRI Based longitudinal immuno‐microenvironment‐monitoring for pancreatic cancer A porcine model of acute necrotizing pancreatitis AhR activation mitigates graft-versus-host disease of the central nervous system by reducing microglial NF-κB signaling c-Rel drives pancreatic cancer metastasis through fibronectin-integrin signaling-induced isolation stress resistance and EMT Common practice of percutaneous drainage in necrotising pancreatitis - a multicentre retrospective study (DRACULA) Elderly male patient presenting with jaundice and cholangitis brings an unexpected histopathological finding, case report InPaFis – results of an open monocenter single-arm phase II study to evaluate the safety of a modified analgesia with indomethacin during pancreatectomy and its influence on clinically relevant pancreatic fistula New-onset diabetes mellitus following pancreatic injury: a systematic review Preoperative prediction of postoperative pancreatic fistula after pancreaticoduodenectomy: determination and validation of a cut-off value for the Roberts Score The distance to arteries predicts the oncological outcome in pancreatic cancer surgery – results from a 3D reconstruction model Editorial: Impact of emerging treatment modalities on stromal cells in the tumour microenvironment Klinische Ergebnisse der vollendoskopischen und mikrochirurgischen Dekompression von lumbalen Spinalkanalstenosen Molekulare und immunologische Veränderungen nach Resektion kolorektaler Lebermetastasen Partial hepatectomy accelerates colorectal metastasis by priming an inflammatory premetastatic niche in the liver Surgical complications requiring late surgical revisions after pancreatoduodenectomy increase postoperative morbidity and mortality Tyrosine phosphatase PTPN11/SHP2 in solid tumors - bull’s eye for targeted therapy? Clinical characteristics and long-term outcomes following pancreatic injury – an international multicenter cohort study Perioperative risk of pancreatic head resection—nomogram-based prediction of severe postoperative complications as a decisional aid for clinical practice Epigenetics in pancreatic ductal adenocarcinoma: Impact on biology and utilization in diagnostics and treatment Extensive preclinical validation of combined RMC-4550 and LY3214996 supports clinical investigation for KRAS mutant pancreatic cancer Onco-immunomodulatory properties of pharmacological interference with RAS-RAF-MEK-ERK pathway hyperactivation Perioperative risk of pancreatic head resection - nomogram-based prediction of severe postoperative complications as a decisional aid for clinical practice Plasma biomarkers for prediction of early tumor recurrence after resection of pancreatic ductal adenocarcinoma The role of immune checkpoint molecules for relapse after allogeneic hematopoietic cell transplantation Pancreatic resection in older patients: a retrospective single-center outcome analysis Targeting mutant KRAS in pancreatic cancer: futile or promising? NF-κB/Rel Transcription factors in pancreatic cancer: focusing on RelA, c-Rel, and RelB Mutant KRAS-driven cancers depend on PTPN11/SHP2 phosphatase Immune checkpoint inhibition for pancreatic ductal adenocarcinoma: current limitations and future options Pharmacotherapeutic Management of Pancreatic Ductal Adenocarcinoma: Current and Emerging Concepts HDACi valproic acid (VPA) and suberoylanilide hydroxamic acid (SAHA) delay but fail to protect against warm hepatic ischemia-reperfusion injury The prognostic influence of intrapancreatic tumor location on survival after resection of pancreatic ductal adenocarcinoma Identifizierung von neuen CD8+ T-Zell-Epitopen aus dem Tumorantigen Zytokeratin 7

Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

Katalog der Deutschen Nationalbibliothek

Dietrich Alexander Ruess (1983-)

A rare case of biliary adenocarcinoma mimicking an abdominal wall soft tissue tumor

Vertical RAS pathway inhibition in pancreatic cancer drives therapeutically exploitable mitochondrial alterations

19Fluorine‐MRI Based longitudinal immuno‐microenvironment‐monitoring for pancreatic cancer

A porcine model of acute necrotizing pancreatitis

AhR activation mitigates graft-versus-host disease of the central nervous system by reducing microglial NF-κB signaling

c-Rel drives pancreatic cancer metastasis through fibronectin-integrin signaling-induced isolation stress resistance and EMT

Common practice of percutaneous drainage in necrotising pancreatitis - a multicentre retrospective study (DRACULA)

Elderly male patient presenting with jaundice and cholangitis brings an unexpected histopathological finding, case report

InPaFis – results of an open monocenter single-arm phase II study to evaluate the safety of a modified analgesia with indomethacin during pancreatectomy and its influence on clinically relevant pancreatic fistula

New-onset diabetes mellitus following pancreatic injury: a systematic review

Preoperative prediction of postoperative pancreatic fistula after pancreaticoduodenectomy: determination and validation of a cut-off value for the Roberts Score

The distance to arteries predicts the oncological outcome in pancreatic cancer surgery – results from a 3D reconstruction model

Editorial: Impact of emerging treatment modalities on stromal cells in the tumour microenvironment

Klinische Ergebnisse der vollendoskopischen und mikrochirurgischen Dekompression von lumbalen Spinalkanalstenosen

Molekulare und immunologische Veränderungen nach Resektion kolorektaler Lebermetastasen

Partial hepatectomy accelerates colorectal metastasis by priming an inflammatory premetastatic niche in the liver

Surgical complications requiring late surgical revisions after pancreatoduodenectomy increase postoperative morbidity and mortality

Tyrosine phosphatase PTPN11/SHP2 in solid tumors - bull’s eye for targeted therapy?

Clinical characteristics and long-term outcomes following pancreatic injury – an international multicenter cohort study

Perioperative risk of pancreatic head resection—nomogram-based prediction of severe postoperative complications as a decisional aid for clinical practice

Epigenetics in pancreatic ductal adenocarcinoma: Impact on biology and utilization in diagnostics and treatment

Extensive preclinical validation of combined RMC-4550 and LY3214996 supports clinical investigation for KRAS mutant pancreatic cancer

Onco-immunomodulatory properties of pharmacological interference with RAS-RAF-MEK-ERK pathway hyperactivation

Perioperative risk of pancreatic head resection - nomogram-based prediction of severe postoperative complications as a decisional aid for clinical practice

Plasma biomarkers for prediction of early tumor recurrence after resection of pancreatic ductal adenocarcinoma

The role of immune checkpoint molecules for relapse after allogeneic hematopoietic cell transplantation

Pancreatic resection in older patients: a retrospective single-center outcome analysis

Targeting mutant KRAS in pancreatic cancer: futile or promising?

NF-κB/Rel Transcription factors in pancreatic cancer: focusing on RelA, c-Rel, and RelB

Mutant KRAS-driven cancers depend on PTPN11/SHP2 phosphatase

Immune checkpoint inhibition for pancreatic ductal adenocarcinoma: current limitations and future options

Pharmacotherapeutic Management of Pancreatic Ductal Adenocarcinoma: Current and Emerging Concepts

HDACi valproic acid (VPA) and suberoylanilide hydroxamic acid (SAHA) delay but fail to protect against warm hepatic ischemia-reperfusion injury

The prognostic influence of intrapancreatic tumor location on survival after resection of pancreatic ductal adenocarcinoma

Identifizierung von neuen CD8+ T-Zell-Epitopen aus dem Tumorantigen Zytokeratin 7